Scheme Information Sheets

UK NEQAS for Paediatric Bilirubin

Scheme Particulars Indicative Details
Accreditation body UKAS
ISO/IEC Accreditation status ISO/IEC 17043:2010
UKAS Accredited Proficiency Testing Provider No 7860
Objective of Scheme Provides EQA coverage for a wide concentration of both unconjugated and conjugated bilirubin, as would be expected in cases of hyperbilirubinaemia. This dedicated Scheme for bilirubin removes the risk of icterus interference in other assays
Pre-, Analytical, Post- status Analytical
Number of distributions per year (nominal) 11
Specimens per distribution 3
Number of Specimens per annum 33
Frequency of distribution Monthly
Scoring system ABC
Material distributed Pooled, liquid human serum with or without exogenous added analyte
Programme Director(s) / Organiser(s) Finlay MacKenzie
Criteria for participation All, but overseas by courier
Nominal sample volume (mL) 0.4
Sample presentation TACs All analytes in the same tube
Data in Chemistry on-line Dashboard Yes
Analyte Approx Range Default Units Target Value B Score Limit (%) C Score Limit (%)
Bilirubinometers 0 – 440 µmol/L GLTM 10.0 10.0
Conjugated bilirubin 0 – 160 µmol/L ALTM 40.0 30.0
Total bilirubin 0 – 440 µmol/L ALTM 10.0 10.0
Abbreviation Expansion
ALTM All Laboratory Trimmed Mean
GLTM Group Laboratory Trimmed Mean – which is the Method Principle Mean
MLTM Method Laboratory Trimmed Mean – usually a manufacturer system / analyser mean
XALTM An external value that may be from a Reference Method System
OGLTM A Method Principle Mean used as the target for all laboratories
OMLTM A specific Method Mean used as a target for all laboratories
MED Median

Last Updated: